Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy.
Alejandro David Bendala EstradaJorge Calderón ParraEduardo Fernández CarracedoAntonio Muiño MíguezAntonio Ramos MartínezElena Muñez RubioManuel Rubio-RivasPaloma AgudoFrancisco Arnalich FernándezVicente Estrada PerezMaría Luisa Taboada MartínezAnxela Crestelo VieitezPaula Maria Pesqueira FontanMarta BustamanteSantiago J FreireIsabel Oriol-BermúdezArturo ArteroJulián Olalla SierraMaría Areses ManriqueH Francisco Javier Carrasco-SánchezVanessa Carolina VentoGema María García GarcíaPablo Cubero-MoraisJosé-Manuel Casas-RojoJesús Millán Núñez-CortésPublished in: BMC infectious diseases (2021)
Bacterial co-infection was uncommon among COVID-19 patients, yet use of antibiotics was high. There is insufficient evidence to support widespread use of empiric antibiotics in these patients. Most may not require empiric treatment and if they do, there is promising evidence regarding azithromycin as a potential COVID-19 treatment.